ADENTRA (TSE:ADEN) Sets New 52-Week High – Still a Buy?

Shares of ADENTRA Inc. (TSE:ADENGet Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as $39.81 and last traded at $39.75, with a volume of 43276 shares traded. The stock had previously closed at $39.04.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on ADEN shares. Canadian Imperial Bank of Commerce increased their price target on ADENTRA from C$41.00 to C$42.00 in a research note on Tuesday, November 11th. National Bank Financial upped their target price on ADENTRA from C$42.50 to C$54.50 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Stifel Nicolaus upped their target price on ADENTRA from C$47.00 to C$51.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Scotiabank increased their target price on ADENTRA from C$41.00 to C$46.00 in a research report on Thursday, January 29th. Finally, Raymond James Financial raised their price target on ADENTRA from C$43.00 to C$46.00 in a research note on Tuesday, November 11th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

View Our Latest Stock Analysis on ADEN

ADENTRA Trading Up 2.9%

The firm has a market cap of $972.55 million, a PE ratio of 22.82 and a beta of 1.56. The company’s 50-day moving average is $35.78 and its 200 day moving average is $34.45.

ADENTRA Company Profile

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

Further Reading

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.